BD (BDX) reached a 52-week high of $227.80 on November 27, 2017. The company saw a 52-week low of $161.30 on December 7, 2017. BD stock’s 50-day moving average stands at $213.80, and its 200-day moving average is $200.33. The company is currently trading higher than these moving averages.
BD released its 4Q17 and fiscal 2017 earnings results on November 2, 2017. That day, the stock rose ~7.7%, registering a record high thanks to the company’s stellar earnings results. For more on that rise, read Becton Dickinson and Company Rose on November 2. Brief highlights of the results are shown in the diagram above. Notably, BD stock fell slightly on the day the company announced its 3Q17 earnings results, on August 3, 2017. The company’s revenue failed to meet analysts’ estimates in the quarter.
On September 13, 2017, BD stock fell ~2.7%. For details, read BD Stock Fell 2.7% on September 13: Should Investors Worry? However, the stock has rallied over the past few months. BD has returned more than 8% over the past month. Over the past three months, BD stock has risen ~14.2%, and over the past six months, it has risen~21.8%.
The stock has returned ~33% over the past year, whereas the SPDR S&P 500 (SPY) and the Health Care Select Sector SPDR ETF (XLV) have returned 18.7% and 18.6%, respectively. As of November 28, 2017, peers Medtronic (MDT), Stryker (SYK), and Abbott Laboratories (ABT) had returned around 9.2%, 38%, and 43%, respectively, over the past year.